Zachary A. Bornholdt (@zabornholdt) 's Twitter Profile
Zachary A. Bornholdt

@zabornholdt

Former x-ray crystallographer leveraging protein engineering skills to develop next-gen immunotherapeutics targeting neglected tropical diseases. #MBP134

ID: 969983895625060352

linkhttps://mappbio.com calendar_today03-03-2018 17:12:36

148 Tweet

73 Followers

38 Following

Bob Cross (@robertwcross1) 's Twitter Profile Photo

Corri from our lab here at UTMB will be at #ASMBiothreats presenting her cutting edge research teasing out the molecular mechanisms of replication differences between species of #ebola , check it out!! UTMB Graduate School of Biomedical Sciences UTMB Provost's Office Institute for Human Infections & Immunity (IHII)

Julian Buchrieser (@jbuchrieser) 's Twitter Profile Photo

Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein. Amazing work by our collaborators, Jan Hellert & Félix Rey! Was great to collaborate with all of you! Nature Communications Institut Pasteur, since 1887 nature.com/articles/s4146…

Defense Threat Reduction Agency (@doddtra) 's Twitter Profile Photo

Reminder that #Ebola still a global concern even if it seems like #COVID19 is only disease making headlines. Don't have to choose one or the other-we work on MANY biothreats #Marburg #smallpox #anthrax #tularemia #plague & more to protect U.S. #warfighter globalbiodefense.com/headlines/ebol…

Jason McLellan (@mclellan_lab) 's Twitter Profile Photo

Fantastic that @sciencemagazine was able to get our manuscript online only days after bioRxiv. Congratulations to Daniel, Nianshuang, KizzyPhD and the rest of the team. We will continue to email coordinates to researchers, just email me. science.sciencemag.org/content/early/…

Nectar Gan (@nectar_gan) 's Twitter Profile Photo

This is beyond shocking China shut down the lab that published the world’s first genome sequence of the #coronavirus last month, barring its scientists from finding ways to contain the outbreak Their only crime? Publishing the sequence before authorities scmp.com/news/china/soc…

Kartik Chandran (@chandranlab) 's Twitter Profile Photo

New bioRxiv from our lab starring MD/PhD student Rob Bortz. We describe a simple antibody assay to measure the stability of the Ebola/Marburg virus spike proteins, with implications for how these viruses invade cells, how some antiviral drugs work doi.org/10.1101/2020.0…

Zachary A. Bornholdt (@zabornholdt) 's Twitter Profile Photo

BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin medicalcountermeasures.gov/newsroom/2020/… Very excited to be a part of this effort being led by Mapp's own Dr. Crystal Moyer!

Bob Cross (@robertwcross1) 's Twitter Profile Photo

Very excited to share our collaboration w/Gilead Sciences & @LarryZeitlin Zachary A. Bornholdt& UTMB Health Institute for Human Infections & Immunity (IHII) demonstrating expansion of therapeutic window of Marburg virus in NHP w/combination therapy of remdesivir and mAb started 6 days post challenge nature.com/articles/s4146…

Very excited to share our collaboration w/<a href="/GileadSciences/">Gilead Sciences</a> &amp; @LarryZeitlin <a href="/ZABornholdt/">Zachary A. Bornholdt</a>&amp; <a href="/utmbhealth/">UTMB Health</a> <a href="/ihii_utmb/">Institute for Human Infections & Immunity (IHII)</a> demonstrating expansion of therapeutic window of Marburg virus in NHP w/combination therapy of remdesivir and mAb started 6 days post challenge nature.com/articles/s4146…
Kartik Chandran (@chandranlab) 's Twitter Profile Photo

Shout out to all the contributors and the amazing jazz improv group that is Prometheus! @MaxFels, Ariel Wirch, Bob Cross, Akaash Mishra, @LarryZeitlin, @virusfusion007, Jason McLellan, Jon Lai, Zachary A. Bornholdt, Laura M. Walker, @usamrdc and many others.🙏@NIAIDFunding /fin

BARDA (@barda) 's Twitter Profile Photo

We’re partnering with Eitr Biologics to develop a therapeutic single domain antibody (sdAb)-based platform to support the discovery of a candidate treatment targeting Sudan ebolavirus. This investment is our first in sdAb technology. ow.ly/rLNf50PPZrG

We’re partnering with Eitr Biologics to develop a therapeutic single domain antibody (sdAb)-based platform to support the discovery of a candidate treatment targeting Sudan ebolavirus. This investment is our first in sdAb technology. ow.ly/rLNf50PPZrG